Fervent Synergies Limited's Board of Directors convened on May 14, 2026, and approved the audited standalone financial results for the quarter and year ended March 31, 2026, in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The board meeting commenced at 12:00 and concluded at 13:15. Statutory auditors M/s. S H Dama & Associates issued an unmodified audit opinion on the annual financial results, affirming the results present a true and fair view in accordance with applicable Indian Accounting Standards (Ind AS).

Financial Performance Overview

For the full year ended March 31, 2026, Fervent Synergies recorded revenue from operations of ₹1,634.76 lakhs, compared to ₹3,245.85 lakhs in the year ended March 31, 2025. Despite the decline in revenue, the company's net profit for FY26 improved to ₹382.00 lakhs from ₹295.36 lakhs in FY25. Total income for FY26 stood at ₹1,635.92 lakhs against ₹3,246.09 lakhs in FY25. The following table summarises the key financial metrics:

Expense Breakdown

Total expenses for FY26 were ₹1,262.41 lakhs, compared to ₹2,951.21 lakhs in FY25. Key expense components for the full year included purchase of stock-in-trade at ₹1,145.41 lakhs (FY25: ₹2,853.13 lakhs), employee benefits expense at ₹46.98 lakhs (FY25: ₹44.30 lakhs), other expenses at ₹54.63 lakhs (FY25: ₹49.97 lakhs), depreciation and amortisation at ₹4.68 lakhs (FY25: ₹3.80 lakhs), and finance costs at ₹0.72 lakhs (FY25: ₹0.02 lakhs). Deferred tax expense for FY26 was ₹1.50 lakhs compared to a deferred tax credit of ₹(0.48) lakhs in FY25, with no current tax recorded in either year.

Segment Performance

The company operates in two reportable segments — the Foods Business Division, which trades in almonds, and the Finance Business Division, which conducts funds lending, investing in fixed-term deposits, and similar securities activities. Segment-wise revenue and profit performance for FY26 and FY25 are presented below:

Total capital employed as at March 31, 2026 stood at ₹5,714.93 lakhs, compared to ₹4,864.18 lakhs as at March 31, 2025. The Finance Business Division accounted for the largest share of capital employed at ₹5,621.11 lakhs as at March 31, 2026.

Balance Sheet Highlights

As at March 31, 2026, total assets stood at ₹5,808.84 lakhs. Non-current assets totalled ₹850.44 lakhs, comprising property, plant and equipment of ₹146.96 lakhs and non-current investment properties of ₹703.03 lakhs. Current assets amounted to ₹4,958.40 lakhs, with loans and advances of ₹4,900.00 lakhs and cash and cash equivalents of ₹29.04 lakhs. Total equity was ₹5,714.93 lakhs, consisting of equity share capital of ₹5,000.00 lakhs (face value ₹10.00 per share) and other equity of ₹714.93 lakhs. Total liabilities stood at ₹93.91 lakhs.

Cash Flow Summary

For the year ended March 31, 2026, net cash used in operating activities was ₹(339.04) lakhs, while net cash used in investing activities was ₹(106.20) lakhs on account of purchase of fixed assets. Net cash generated from financing activities was ₹468.75 lakhs, primarily from proceeds from issue of convertible warrants. The net increase in cash and cash equivalents for the year was ₹23.51 lakhs, with closing cash and cash equivalents at ₹29.04 lakhs compared to ₹5.53 lakhs at the beginning of the year.

Corporate Developments

In addition to approving the financial results, the board also approved the re-appointment of Mr. Jayesh Doshi as Internal Auditor of the company for FY 2026-27. Mr. Jayesh Doshi is a commerce graduate from Mumbai University (1991) with experience in business and financial matters, and serves as proprietor of his firm based at 211/23, Satyam, 2nd Floor, R.N.N. Road, Ghatkopar East, Mumbai-400077. The financial results were reviewed by the Audit Committee prior to board approval and have been prepared in accordance with Ind AS under Section 133 of the Companies Act, 2013, and in compliance with Regulation 33 of the SEBI (LODR) Regulations, 2015.

Fervent Synergies Limited has notified the stock exchange of an upcoming Board of Directors meeting, scheduled for Thursday, May 14, 2026. The intimation, dated May 4, 2026, was submitted to BSE Limited in accordance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Details

The meeting is set to be held at the registered office of the company and will primarily focus on reviewing and approving the audited financial results for the year ended March 31, 2026. The key details of the scheduled board meeting are outlined below:

Trading Window Closure

In line with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and amendments made thereunder, read with the company's Code of Conduct for Prevention of Insider Trading, Fervent Synergies has implemented a trading window closure. The trading window was closed from April 1, 2026, and will remain shut until 48 hours after the declaration of the financial results. This restriction applies to employees of the company, including Designated Persons and their immediate relatives.

Signatory Details

The intimation was signed by Sanjay P. Thakkar, Managing Director (DIN: 00588420), on behalf of Fervent Synergies Limited.